Examining the Phase 2b BEACON-IPF Trial of Bexotegrast for Patients with IPF
Time: 8:00 am
day: Day One
Details:
• Exploring key study design and attributes of the phase 2b trial
• Exploring the selected clinical study design including patient populations, biomarker panel, endpoint selection and beyond
• Looking on to the phase 3 study, what is next?
